-
公开(公告)号:AU2006299243A1
公开(公告)日:2007-04-12
申请号:AU2006299243
申请日:2006-09-18
Applicant: BASF AG
Inventor: KNOLL ROLF , REINDL ANDREAS , LANG CHRISTINE , BOTTNER MEWES , VEEN MARKUS , BUDDE ECKHARD
IPC: C12N1/20 , A61K8/99 , A61K35/74 , A61K35/744 , A61K35/747
Abstract: Described are microorganisms which are able to inhibit the formation of foot malodor by skin microorganisms. Also described are compositions comprising such microorganisms as well as the use of such microorganisms in cosmetic, prophylactic or therapeutic applications.
-
公开(公告)号:AU2005281796A1
公开(公告)日:2006-03-16
申请号:AU2005281796
申请日:2005-09-09
Applicant: BASF AG
Inventor: KNOLL ROLF , BUDDE ECKHARD , VEEN MARKUS , LANG CHRISTINE , BOETTNER MEWES , RYSER MARTIN , KAESLER BRUNO
IPC: C12N1/20 , A23L13/60 , A23L15/00 , A23L17/00 , A23L27/60 , A23L29/00 , A61K35/74 , A61K35/747 , C12R1/225
Abstract: The present invention relates to a microorganism belonging to the group of lactic acid bacteria characterized in that it is capable of specifically binding to Streptococcus mutans, wherein the specific binding is (i) resistant to heat treatment; and/or (ii) resistant to protease treatment; and/or (iii) calcium-dependent; and/or (iv) formed within a pH range between 4.5 and 8.5; and/or (v) formed in the presence of saliva. Preferably, the specific binding can be assayed as follows: (a) growing said microorganism to stationary phase; (b) mixing said microorganism with Streptococcus mutans which has been grown to stationary phase; (c) incubating the mixture obtained in step (b) under conditions allowing the formation of aggregates of said microorganism and Streptococcus mutans and (d) detecting aggregates by the occurrence of a pellet. Another aspect of the present invention is an analog or fragment of said microorganism which is thermally inactivated or lyophilized, wherein said analog or fragment retains the capability of specifically binding to Streptococcus mutans. In addition, the present invention encompasses compositions and additives for food, feed or drinks comprising the microorganism belonging to the group of lactic acid bacteria which specifically bind to Streptococcus mutans or an analog or fragment thereof. Moreover, uses of said microorganism or said analog or fragment thereof for the preparation of an anticariogenic or pharmaceutical composition or anticariogenic food or feedstuff as well as methods for producing said compositions or food or feedstuff are provided by the present invention.
-
公开(公告)号:DE10203352A1
公开(公告)日:2003-07-31
申请号:DE10203352
申请日:2002-01-29
Applicant: BASF AG
Inventor: LANG CHRISTINE , VEEN MARKUS
Abstract: The invention relates to a method for the production of 7-dehydrocholesterol and/or the biosynthetic intermediate or subsequent products thereof by the cultivation of organisms, in particular, yeasts which show an increased activity of at least one activity, selected from delta-8/delta-7 isomerisation activity, delta-5 desaturase activity or delta-24 reductase activity. The invention further relates to the nucleic acid constructs necessary for production of the genetically-modified organisms and the genetically-modified organisms, in particular, the yeasts themselves.
-
公开(公告)号:AU2005281796C1
公开(公告)日:2014-01-23
申请号:AU2005281796
申请日:2005-09-09
Applicant: BASF AG
Inventor: KAESLER BRUNO , KNOELL ROLF , BOETTNER MEWES , BUDDE ECKHARD , LANG CHRISTINE , RYSER MARTIN , VEEN MARKUS
IPC: C12N1/20 , A23L13/60 , A23L15/00 , A23L17/00 , A23L27/60 , A23L29/00 , A61K35/74 , A61K35/747 , C12R1/225
Abstract: The present invention relates to a microorganism belonging to the group of lactic acid bacteria characterized in that it is capable of specifically binding to Streptococcus mutans, wherein the specific binding is (i) resistant to heat treatment; and/or (ii) resistant to protease treatment; and/or (iii) calcium-dependent; and/or (iv) formed within a pH range between 4.5 and 8.5; and/or (v) formed in the presence of saliva. Preferably, the specific binding can be assayed as follows: (a) growing said microorganism to stationary phase; (b) mixing said microorganism with Streptococcus mutans which has been grown to stationary phase; (c) incubating the mixture obtained in step (b) under conditions allowing the formation of aggregates of said microorganism and Streptococcus mutans and (d) detecting aggregates by the occurrence of a pellet. Another aspect of the present invention is an analog or fragment of said microorganism which is thermally inactivated or lyophilized, wherein said analog or fragment retains the capability of specifically binding to Streptococcus mutans. In addition, the present invention encompasses compositions and additives for food, feed or drinks comprising the microorganism belonging to the group of lactic acid bacteria which specifically bind to Streptococcus mutans or an analog or fragment thereof. Moreover, uses of said microorganism or said analog or fragment thereof for the preparation of an anticariogenic or pharmaceutical composition or anticariogenic food or feedstuff as well as methods for producing said compositions or food or feedstuff are provided by the present invention.
-
公开(公告)号:CA2518493A1
公开(公告)日:2004-09-30
申请号:CA2518493
申请日:2004-03-12
Applicant: BASF AG
Inventor: VEEN MARKUS , KUENKEL ANDREAS , LANG CHRISTINE
Abstract: The invention relates to a method for producing ergosta-5,7-dienol and/or biosynthetic intermediate and/or secondary products thereof by cultivating genetically modified organisms. The invention also relates to the geneticall y modified organisms themselves, particularly yeasts.
-
公开(公告)号:AU2005281796B2
公开(公告)日:2011-06-16
申请号:AU2005281796
申请日:2005-09-09
Applicant: BASF AG
Inventor: KNOLL ROLF , BUDDE ECKHARD , VEEN MARKUS , LANG CHRISTINE , BOETTNER MEWES , RYSER MARTIN , KAESLER BRUNO
IPC: C12N1/20 , A23L13/60 , A23L15/00 , A23L17/00 , A23L27/60 , A23L29/00 , A61K35/74 , A61K35/747 , C12R1/225
Abstract: The present invention relates to a microorganism belonging to the group of lactic acid bacteria characterized in that it is capable of specifically binding to Streptococcus mutans, wherein the specific binding is (i) resistant to heat treatment; and/or (ii) resistant to protease treatment; and/or (iii) calcium-dependent; and/or (iv) formed within a pH range between 4.5 and 8.5; and/or (v) formed in the presence of saliva. Preferably, the specific binding can be assayed as follows: (a) growing said microorganism to stationary phase; (b) mixing said microorganism with Streptococcus mutans which has been grown to stationary phase; (c) incubating the mixture obtained in step (b) under conditions allowing the formation of aggregates of said microorganism and Streptococcus mutans and (d) detecting aggregates by the occurrence of a pellet. Another aspect of the present invention is an analog or fragment of said microorganism which is thermally inactivated or lyophilized, wherein said analog or fragment retains the capability of specifically binding to Streptococcus mutans. In addition, the present invention encompasses compositions and additives for food, feed or drinks comprising the microorganism belonging to the group of lactic acid bacteria which specifically bind to Streptococcus mutans or an analog or fragment thereof. Moreover, uses of said microorganism or said analog or fragment thereof for the preparation of an anticariogenic or pharmaceutical composition or anticariogenic food or feedstuff as well as methods for producing said compositions or food or feedstuff are provided by the present invention.
-
公开(公告)号:CA2633657A1
公开(公告)日:2007-04-12
申请号:CA2633657
申请日:2006-09-18
Applicant: BASF AG
Inventor: BOETTNER MEWES , LANG CHRISTINE , REINDL ANDREAS , BUDDE ECKHARD , VEEN MARKUS , KNOELL ROLF
IPC: C12N1/20 , A61K8/99 , A61K35/74 , A61K35/744 , A61K35/747
Abstract: Described are microorganisms which are able to inhibit the formation of foot malodor by skin microorganisms. Also described are compositions comprising such microorganisms as well as the use of such microorganisms in cosmetic, prophylactic or therapeutic applications.
-
公开(公告)号:CA2623591A1
公开(公告)日:2007-03-22
申请号:CA2623591
申请日:2006-09-13
Applicant: BASF AG
Inventor: BOETTNER MEWES , REINDL ANDREAS , KNOELL ROLF , LANG CHRISTINE , VEEN MARKUS , BUDDE ECKHARD
Abstract: Described are microorganisms which are able to suppress the production of malodorous compounds by axillary bacteria. Also described are compositions comprising such microorganisms as well as the use of such micoorganisms in cosmetic, prophylactic or therapeutic applications.
-
公开(公告)号:DE10312314A1
公开(公告)日:2004-09-30
申请号:DE10312314
申请日:2003-03-19
Applicant: BASF AG
Inventor: KUENKEL ANDREAS , VEEN MARKUS , LANG CHRISTINE
Abstract: The present invention relates to a method for the production of ergosta-5,7-dienol and/or its biosynthetic intermediates and/or metabolites by culturing genetically modified organisms, and to the genetically modified organisms, in particular yeasts, themselves.
-
-
-
-
-
-
-
-